SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
686 Curious thread! BGEN hit $51 9/16 today, pretty much of an all time high! Gee,mike head-7/7/1998
685 Harold, I don't. IMHO, any pipeline news to increase the visibility of yeaHong-Lee Yu-7/1/1998
684 Hong-Lee, today Berlex "announced that results from an interim analysis ofHarold Engstrom-6/30/1998
683 Harold, Lehman analysts may increase the target price once Biogen beats the esHong-Lee Yu-6/25/1998
682 "Biogen's royalty will move from $167 million ('99) to a new estimHarold Engstrom-6/25/1998
681 All, Check Lehman's research - upgrading to 1-BUY with target price of 60 Hong-Lee Yu-6/25/1998
680 Harold, Sincere thanks for the meeting summary from those of that are mostly lMichelino-6/22/1998
679 No, but Jim Tobin made sure to point out to those present that the company hadHarold Engstrom-6/22/1998
678 Harold, Did management mention what they are going to do with their money ? IHong-Lee Yu-6/22/1998
677 Thanks for the encouragement and information. I'm never sure if more than Harold Engstrom-6/21/1998
676 Harold, fine post and I appreciate your good work for the thread. I posted a Bwe-6/21/1998
675 Harold- I, too, appreciate your report on the shareholder meeting. And for yoPuddleGlum-6/21/1998
674 Biogen did say they are well prepared to protect their CD40L position, but the Harold Engstrom-6/20/1998
673 Harold, Thanks for the excellent report on the shareholder meeting. I agree thVector1-6/20/1998
672 Forgot an interesting 5C8 note: New England Journal of Medicine article this weHarold Engstrom-6/19/1998
671 Notes on Biogen shareholder meeting, 19 June 1998, 10AM: Jim Vincent started mHarold Engstrom-6/19/1998
670 Annual meeting Friday, 19 June 1998. (eom)Harold Engstrom-6/12/1998
669 Does anyone think the low volume this week is very abnormal? It is past 1pm anHarold Engstrom-6/5/1998
668 To a lay person, it seems positive. May have to wait for Phase III for definitStanley Cowen-6/4/1998
667 Anyone capable of diciphering whether the Phase II trial results that were annoHarold Engstrom-5/29/1998
666 Harold, Here is CVT-124 news CV Therapeutics CVT-124 Shows Renal Function In Hong-Lee Yu-5/29/1998
665 Results for CVT-124 and 5C8 were to have been released at conferences this quarHarold Engstrom-5/26/1998
664 Rick, While sometimes patent fights wind up in court, and BGEN has had their shVector1-5/21/1998
663 BGEN has composition of matter. That means that there will either be litigatioscaram(o)uche-5/21/1998
662 o.k.---Rick--I assume that means they are competitors. So who does it look likwpckr-5/21/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News